INTECH Investment Management’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$287K Hold
12,724
﹤0.01% 1604
2026
Q1
$318K Sell
12,724
-9,087
-42% -$256K ﹤0.01% 1550
2025
Q4
$686K Sell
21,811
-2,436
-10% -$80.8K 0.01% 1340
2025
Q3
$865K Sell
24,247
-2,995
-11% -$137K 0.01% 1255
2025
Q2
$1.57M Sell
27,242
-1,147
-4% -$64.9K 0.01% 922
2025
Q1
$1.65M Buy
28,389
+10,002
+54% +$683K 0.02% 871
2024
Q4
$1.48M Buy
18,387
+6,165
+50% +$527K 0.01% 893
2024
Q3
$979K Buy
+12,222
New +$868K 0.01% 818

Other funds holding PRCT

INTECH Investment Management's PRCT Position: Q2 2026 in Review

INTECH Investment Management held its Procept Biorobotics (PRCT) position steady in Q2 2026 at 12,724 shares worth $287K. The position accounts for ﹤0.01% of the portfolio, ranked #1604.

INTECH Investment Management first reported a position in PRCT in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.65M in Q1 2025. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • INTECH Investment Management held 12,724 shares of Procept Biorobotics worth $287K as of Q2 2026.
  • INTECH Investment Management left its Procept Biorobotics share count unchanged in Q2 2026.
  • Procept Biorobotics made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1604 holding.
  • INTECH Investment Management first reported a position in Procept Biorobotics in Q3 2024 and has held it in 8 quarters since.
  • INTECH Investment Management's Procept Biorobotics position peaked at $1.65M in Q1 2025.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.